Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity
NCT ID: NCT07104461
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2023-06-09
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Increasing protein intake is a commonly applied nutritional approach to appetite regulation. The increase in protein intake is often achieved by supplementation, using proteins isolated from dairy, such as whey and casein. However, with more individuals following plant-based diets over recent years, the interest in plant-based protein supplements has increased. While dairy-based proteins are well-characterised, the appetite regulatory characteristics of plant-based proteins have not yet been fully elucidated.
The main aim of this study is to investigate the effects of protein-enriched food items on appetite regulation compared to a standard carbohydrate-rich meal. Furthermore, this study will investigate whether there are any differences in appetite-related hormonal responses to a plant protein-containing meal replacement shake (containing rice and pea protein) or a potato protein-enriched standard carbohydrate-based meal compared to a whey protein-enriched standard carbohydrate-based meal.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Protein-enriched Diet on Body Composition and Appetite
NCT01634048
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake
NCT03154606
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake: A Clinical Screening Study
NCT03595436
Whey Protein Study - Identification of Sustainable Satiety
NCT02246543
Isolating and Exploiting the Mechanisms That Link Breakfast and Human Health - Intervention
NCT04417205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Healthy male participants (between the ages of 18 to 50 years) will receive four different isocaloric intervention meals with the same mass, on separate visit days, following a minimum of 8 hours overnight fast. The four meals will contain oat porridge prepared with coconut milk as a control, oat porridge prepared with coconut milk with added whey or potato protein isolates, and a complete meal replacement shake containing plant-based pea and rice proteins. The intervention meals will be followed by a standardised pasta-based ready meal after the 3-hour observation period. All participants will observe at least a two-day washout period between the differing treatments.
Biological samples (blood) will be collected at various times during the visit. Blood samples will be collected at baseline 0 min prior (T0), then at 30 min (T30), 60 min (T60), 120 min (T120) and 180 min (T180) after the intervention meal consumption.
In addition, pertinent questionnaires, Visual Analogue Scale \[VAS\] for assessing satiety and VAS for assessing intervention meals' perception and palatability will be collected. VAS for the assessment of satiety will be collected at T0, T30, T60, T120 and T180 and VAS assessing the perception and palatability of the intervention meals will be collected immediately following meal consumption.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oat porridge
Control Meal (9.5 g total protein)
Oat porridge
Oat flakes, 81g (equivalent to 9 g of protein), were presented to participants in the form of porridge, prepared with 500 mL coconut milk (equivalent to 0.5 g of protein) and 10 g of zero calorie sugar free syrup.
The total energy content was equivalent to 400 Kcal.
Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study.
Oat porridge with whey protein
(total protein 40.5 g; of which whey protein isolate contributed 34.2 g of protein)
Whey protein isolate
Whey protein isolate, 38g (equivalent to 34.2 g of protein), was presented to participants in the form of a porridge.
Other ingredients in the whey protein enriched porridge:
* Oat flakes 54 g (equivalent to 6 g of protein)
* Coconut milk 300 mL (equivalent to 0.3 g of protein)
* Water 150 mL
* Zero calorie sugar free syrup 10 g
The total energy content was equivalent to 401.74 Kcal.
Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study
Oat porridge with potato protein
(total protein 40.6 g; of which potato protein isolate contributed 34.39 g of protein)
Potato protein isolate
Potato protein isolate, 38g (equivalent to 34.39 g of protein), was presented to participants in the form of a porridge.
Other ingredients in the potato protein enriched porridge:
* Oat flakes 54 g (equivalent to 6 g of protein)
* Coconut milk 300 mL (equivalent to 0.3 g of protein)
* Water 150 mL
* Zero calorie sugar free syrup 10 g
The total energy content equiv. 401.36 Kcal.
Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study.
Meal replacement shake
(total protein 40 g, mostly from pea protein and brown rice protein isolates)
Meal replacement shake
A meal replacement, 90 g (equivalent to 40 g of total protein), was presented to participants in the form of a shake.
Other ingredients in the meal replacement shake:
\- Water 500 mL
The total energy was equivalent to 400 Kcal
Participants were instructed to consume the entire meal replacement shake presented to them in 15 minutes on an empty stomach when attending the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oat porridge
Oat flakes, 81g (equivalent to 9 g of protein), were presented to participants in the form of porridge, prepared with 500 mL coconut milk (equivalent to 0.5 g of protein) and 10 g of zero calorie sugar free syrup.
The total energy content was equivalent to 400 Kcal.
Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study.
Whey protein isolate
Whey protein isolate, 38g (equivalent to 34.2 g of protein), was presented to participants in the form of a porridge.
Other ingredients in the whey protein enriched porridge:
* Oat flakes 54 g (equivalent to 6 g of protein)
* Coconut milk 300 mL (equivalent to 0.3 g of protein)
* Water 150 mL
* Zero calorie sugar free syrup 10 g
The total energy content was equivalent to 401.74 Kcal.
Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study
Potato protein isolate
Potato protein isolate, 38g (equivalent to 34.39 g of protein), was presented to participants in the form of a porridge.
Other ingredients in the potato protein enriched porridge:
* Oat flakes 54 g (equivalent to 6 g of protein)
* Coconut milk 300 mL (equivalent to 0.3 g of protein)
* Water 150 mL
* Zero calorie sugar free syrup 10 g
The total energy content equiv. 401.36 Kcal.
Participants were instructed to consume the entire meal presented to them in 15 minutes on an empty stomach when attending the study.
Meal replacement shake
A meal replacement, 90 g (equivalent to 40 g of total protein), was presented to participants in the form of a shake.
Other ingredients in the meal replacement shake:
\- Water 500 mL
The total energy was equivalent to 400 Kcal
Participants were instructed to consume the entire meal replacement shake presented to them in 15 minutes on an empty stomach when attending the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lean and Overweight subjects (BMI 18.5 - 30 kg/m2)
* Sedentary and physically active subjects
* Healthy subjects
Exclusion Criteria
* \<18, \>50 years
* Dieting
* Consumption of \>14 units of alcohol/week
* Allergies to test foods/drinks
* Illnesses or on medication (with a possible effect on taste and/or appetite)
* Devices such as pacemakers
* Smokers
* Gastrointestinal disorders
* Eating disorders
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Westminster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Gulrez Zariwala
Professor of Translational Physiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed Gulrez Zariwala, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Westminster
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Nutraceuticals School of Life Sciences, University of Westminster
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001.
Guo H, Guo Q, Li Z, Wang Z. Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis. Front Pharmacol. 2024 Nov 13;15:1461398. doi: 10.3389/fphar.2024.1461398. eCollection 2024.
Ismail I, Hwang YH, Joo ST. Meat analog as future food: a review. J Anim Sci Technol. 2020 Mar;62(2):111-120. doi: 10.5187/jast.2020.62.2.111. Epub 2020 Mar 31.
Monami M, Nreu B, Scatena A, Cresci B, Andreozzi F, Sesti G, Mannucci E. Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials. Diabetes Obes Metab. 2017 Sep;19(9):1233-1241. doi: 10.1111/dom.12926. Epub 2017 Jun 20.
Patel S. Emerging trends in nutraceutical applications of whey protein and its derivatives. J Food Sci Technol. 2015 Nov;52(11):6847-58. doi: 10.1007/s13197-015-1894-0. Epub 2015 Jun 9.
Santesso N, Akl EA, Bianchi M, Mente A, Mustafa R, Heels-Ansdell D, Schunemann HJ. Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur J Clin Nutr. 2012 Jul;66(7):780-8. doi: 10.1038/ejcn.2012.37. Epub 2012 Apr 18.
Zushin PH, Wu JC. Evaluating the benefits of the early use of GLP-1 receptor agonists. Lancet. 2025 Jan 18;405(10474):181-183. doi: 10.1016/S0140-6736(24)02255-4. Epub 2024 Nov 12. No abstract available.
Related Links
Access external resources that provide additional context or updates about the study.
NHS. (2023). Obesity - Treatment
WHO. (2024). Obesity and overweight. World Health Organization.
WHO. (2015). World health statistics 2015. World Health Organization
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ETH2223-1377
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.